Reichert; Uwe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reichert; Uwe.The latest application filed is for "auxiliary assembly of an internal combustion engine".

Company Profile

0.14.7

Reichert; Uwe - Schluchtern DE
Reichert; Uwe - Schluchtem DE
Reichert; Uwe - Pont-du-Loup FR
Reichert, Uwe - Schl?uuml;chtern DE
Reichert; Uwe - Le Bar S/Loup FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Auxiliary assembly of an internal combustion engine Grant 8,274,194 - Gruendl , et al. September 25, 2	2012-09-25
Auxiliary Assembly of an Internal Combustion Engine App 20100219711 - Gruendl; Andreas ; et al.	2010-09-02
Device for sensing a displacement for a linear drive, and linear drive Grant 7,423,421 - Reichert , et al. September 9, 2	2008-09-09
Solenoid plunger system with an adjustable magnetic flux Grant 7,205,685 - Reichert , et al. April 17, 2	2007-04-17
Device for sensing a displacement for a linear drive, and linear drive App 20060208724 - Reichert; Uwe ; et al.	2006-09-21
Solenoid plunger system with an adjustable magnetic flux App 20060145545 - Reichert; Uwe ; et al.	2006-07-06
Solenoid plunger system with an impact damping mechanism Grant 6,913,242 - Reichert , et al. July 5, 2	2005-07-05
Valve block and valve block assembly for producing such a valve block Grant 6,820,634 - Reichert , et al. November 23, 2	2004-11-23
Use of a RAR-.gamma.-specific agonist ligand for increasing the rate of apoptosis Grant 6,686,386 - Fesus , et al. February 3, 2	2004-02-03
Solenoid plunger system with an impact damping mechanism App 20030178594 - Reichert, Uwe ; et al.	2003-09-25
Use of a RAR-.gamma.-specific agonist ligand for increasing the rate of apoptosis Grant 6,593,359 - Fesus , et al. July 15, 2	2003-07-15
Valve block and valve block assembly for producing such a valve block App 20030102030 - Reichert, Uwe ; et al.	2003-06-05
Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis App 20030092758 - Fesus, Laszlo ; et al.	2003-05-15
Use of a RAR-.gamma.-specific agonist ligand for increasing the rate of apoptosis Grant 6,506,796 - Fesus , et al. January 14, 2	2003-01-14
Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis App 20010018456 - Fesus, Laszlo ; et al.	2001-08-30
.gamma.-RAR antagonist ligand or .alpha.-RAR agonist ligand as an apoptosis inhibitor Grant 6,063,797 - Fesus , et al. May 16, 2	2000-05-16
Stimulating the differentiation of preadipocytic cells and therapies based thereon Grant 5,854,292 - Ailhaud , et al. December 29, 1	1998-12-29
Stimulating the differentiation of predipocytic cells and therapies based thereon Grant 5,827,897 - Ailhaud , et al. October 27, 1	1998-10-27
Electro-pneumatic bus Grant 5,616,965 - Wolf , et al. April 1, 1	1997-04-01
Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol Grant 5,556,844 - Reichert , et al. September 17, 1	1996-09-17
Fluid containing coaxial tube for control systems Grant 5,433,252 - Wolf , et al. July 18, 1	1995-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.